International Cannabis Weekly: 286

WASHINGTON BILL TO ALLOW CROSS-STATE CANNABIS SALES APPROVED

Legislation to eventually allow Washington State cannabis companies to engage in interstate commerce passed out of a House committee on Tuesday. A companion bill on the Senate side cleared its own committee hurdle last month.

If the legislation is enacted, interstate cannabis trade would depend on a policy change at the federal level: either a law ‘to allow the interstate transfer of cannabis’ between legal businesses or an opinion from the U.S. Department of Justice ‘allowing or tolerating’ cannabis commerce across state lines, the bill says.

READ MORE »

MALTA PLANS TO SLASH PROHIBITIVE FEES FOR CANNABIS CLUBS

READ MORE »

GREECE HOPES TO SEE ACCESS TO LEGAL CANNABIS MEDICINES IN 2023

READ MORE »

• Officials in western Ukraine have launched a project to develop a hemp industrial park.
• France reports highly positive patient response to medical cannabis trial; results unlikely to impact decision to legalise.
• Has GW Pharmaceuticals – Now Jazz Pharmaceuticals – Knee-Capped The CBD Industry?
• A study in the UK will explore the symptoms of rare childhood epilepsies and how medicinal cannabis can help.
• Oxford scientists to launch trial to study the effects of CBD as a treatment for psychosis.

SPONSOR THE EUROPEAN CANNABIS REPORT: 8TH EDITION – APPLICATIONS OPEN

Since 2017, Prohibition Partners has published 30+ industry reports, providing reliable and credible data on commercial opportunities, market forecasts and the regulatory environment in key cannabis markets globally. The Prohibition Partners report series are amongst the most widely-read in the industry, with over 150,000 readers globally.

Our report sponsorship packages offer unique brand awareness and business development opportunities. Sponsorship applications for our flagship report, The European Cannabis Report (8th Edition), are now open. Position your brand as a leader in the European cannabis industry and get in front of retailers, investors and those in complementary industries looking to get a foothold in the cannabis space.

REQUEST MEDIA DECK »

• Twitter’s new policy allows ads for cannabis, THC products in the US after going through an approval process.
• Kentucky lawmakers have filed eight cannabis bills so far this year – here’s what they say.
• The DEA has declared that Delta-8 and -9 THCO do not meet the federal definition of legal hemp.
• Rhode Island bill to criminalise cannabis use in groups of three or more people is being rewritten.
• North Carolina is struggling with CBD policy in the absence of federal regulations regarding finished products.
• California officials announce that they’ve awarded US$15 million in grants to support the local cannabis industry.
• Ayr Wellness announces agreement to sell Arizona assets and option to acquire Ohio dispensary licences.
• Oklahoma voters will head to the polls to decide on whether to legalise recreational cannabis statewide.

BUSINESS OF CANNABIS: NYC SESSIONS | LESS THAN 1 WEEK TO GO

At NYC Sessions on 23 February, we’ll be looking ahead at how the unique regulatory landscape in New York might look ten years from now, with speakers from Leafly and New York State Office of Cannabis Management.

Join us for an evening of exclusive talks, premium networking opportunities, an open bar and access to Work’n’Roll’s on-site consumption lounge.

GET TICKETS »

• Aurora Cannabis has completed a transformation plan delivering C$340 million in annualised savings.
• Item 9 Labs Corp. secures financing to complete acquisition of Sessions Cannabis in March 2023.
• Last week, Manitoba added another item to its long list of exported products – medical cannabis.
• Trees Corporation has announced its fourth-quarter financial results for the three- and twelve-month periods.

• Health Secretariat of São Paulo constitutes a working group to implement the cannabis law in the SUS.
• Khiron Life Sciences Corp. closes revolving credit facility with financing company in Colombia.
• The president of the ALEP has enacted the bill that grants access to cannabis-based medicines in Brazil.
• Law approved for the use of medicinal cannabis in the São Paulo SUS; now its regulation is urgent.

• Delta 9 Cannabis Inc. has made its first international shipment to an unnamed Australian customer.
• Vitura Health has reported record revenue and profit for the half year ended December 2022.
• CannaCare to pay Elixinol Wellness more than A$800,000 following the mutual termination of a proposed deal.
• Rua Bioscience appoints Paul Naske as CEO, with Anna Stove returning to the board as chair.
• The Deputy Prime Minister of Malaysia to discuss with the Ministry of Health how to regulate medical cannabis.
• Halucenex Life Sciences Inc. is exploring opportunities to register its synthetic psilocybin formulation.

CANNABIS EUROPA LONDON | AGENDA NOW LIVE

The official agenda for Cannabis Europa London on 2-3 May is now LIVE on the Cannabis Europa website and event app. The two-day programme provides unrivalled access to unmissable insight from 50+ expert speakers, across 15 panels.

This May 2-3, Cannabis Europa returns to the Barbican Centre. Join us for two days of exceptional networking opportunities, industry-defining discussions with genuine decision makers and future predictions for the growing European cannabis industry.

SEE AGENDA »

• Syqe Medical announces agreement with Israeli Ministry of Defence to provide the SyqeAir technology to veterans.
• South Africa is set to see some major changes to tobacco, vape and cannabis smoking this year.
• For the first time a Canadian company is buying cannabis stores in Israel, in cooperation with Prof. Grotto.